CD8A and neoplasm: A study by Li et al. showed that PD-1+ CD8+ T cells, which are known to be enriched for tumor-specific cells, are expanded in circulation following CCRT [49], while another study demonstrated a decrease in the PD-1+ CD8+ T cell population [47].